Koen Van Vijver

Koen Van De Vijver

UNVERIFIED PROFILE

Are you Koen Van De Vijver?   Register this Author

Register author
Koen Van Vijver

Koen Van De Vijver

Publications by authors named "Koen Van De Vijver"

75Publications

2046Reads

46Profile Views

1PubMed Central Citations

Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead toward personalized treatment.

Int J Cancer 2020 Feb 3. Epub 2020 Feb 3.

Medical Oncology, Department of Internal Medicine and Pediatrics, Ghent University Hospital, Ghent, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.32893DOI Listing
February 2020

Imaging depth variations in hyperspectral imaging: Development of a method to detect tumor up to the required tumor-free margin width.

J Biophotonics 2019 Nov 23;12(11):e201900086. Epub 2019 Jul 23.

Department of Surgery, Netherlands Cancer Institute, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jbio.201900086DOI Listing
November 2019

SATB2 is Consistently Expressed in Squamous Morules Associated With Endometrioid Proliferative Lesions and in the Stroma of Atypical Polypoid Adenomyoma.

Int J Gynecol Pathol 2019 Sep;38(5):397-403

Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK (W.G.M.) Department of Pathology, Ghent University Hospital, Cancer Research Institute Ghent (CRIG), Ghent, Belgium (K.V.d.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000544DOI Listing
September 2019

Broadband hyperspectral imaging for breast tumor detection using spectral and spatial information.

Biomed Opt Express 2019 Sep 7;10(9):4496-4515. Epub 2019 Aug 7.

Department of Surgery, Netherlands Cancer Institute, Plesmanlaan 121, 1066CX Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1364/BOE.10.004496DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6757478PMC
September 2019

Practical Guidance for Measuring and Reporting Surgical Margins in Vulvar Cancer.

Int J Gynecol Pathol 2019 Aug 26. Epub 2019 Aug 26.

Departments of Obstetrics and Gynecology (K.E.K., M.I.E.V.P.) Pathology (V.T.H.B.M.S., T.B.), Leiden University Medical Centre, Leiden, The Netherlands Department of Pathology, Ghent University Hospital, Gent (K.K.V.D.V.) Department of Pathology, University Hospitals Leuven, Leuven (A.S.V.R.), Belgium Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada (C.B.G.) Department of Cellular Pathology, Princess Alexandra Hospital, Harlow, Essex (S.A.) Department of Cellular Pathology, St. James's University Hospital, Leeds (D.A.) Department of Cellular Pathology, Barts Health NHS Trust, London (A.F., N.S.) Department of Cellular Pathology, University Hospitals Birmingham NHS Trust, Birmingham (R.G., B.T., J.V.) Department of Pathology, Airedale General Hospital, Keighley (N.R.G.) Department of Cellular Pathology, Stepping Hill Hospital, Stockport (R.H.) Department of Histopathology, Manor Hospital, Walsall Healthcare NHS Trust, Walsall (Y.L.H.) Department of Pathology, Belfast Health and Social Care Trust, Belfast (W.G.M.) Department of Cellular Pathology, Royal United Hospital, Bath (P.M.) Department of Pathology, Cambridge University Hospitals NHS Trust, Cambridge (B.R.) Department of Pathology, Royal Derby Hospital, Derby (G.V.S) Department of Histopathology, The Royal Sussex County Hospital, Brighton (M.V.), UK Division of Gynecologic, Breast & Perinatal Pathology, University Hospital Leipzig, Leipzig, Germany (L.C.H.) Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York (K.J.P.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000631DOI Listing
August 2019

Hyperspectral Imaging for Resection Margin Assessment during Cancer Surgery.

Clin Cancer Res 2019 06 18;25(12):3572-3580. Epub 2019 Mar 18.

Department of Surgery, The Netherlands Cancer Institute, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-2089DOI Listing
June 2019

Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multi-institutional Study.

Int J Gynecol Pathol 2019 May;38(3):205-215

Department of Pathology, Wayne State University (E.A., B.A., S.B., R.A.-F.) Department of Pathology, St John's Providence Hospital (M.K.), Detroit, Michigan Department of Pathology, Massachusetts General Hospital, Harvard University, Boston, Massachusetts (L.L., K.V.D.V., E.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000497DOI Listing
May 2019

Gene Promoter Methylation in Endometrial Carcinogenesis.

Pathol Oncol Res 2019 Apr 14;25(2):659-667. Epub 2018 Nov 14.

Department of Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-018-0489-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6449282PMC
April 2019

Predictive Histologic Factors in Carcinosarcomas of the Uterus: A Multiinstitutional Study.

Int J Gynecol Pathol 2018 Apr 3. Epub 2018 Apr 3.

Department of Pathology, Wayne State University (E.A., B.A., S.B., R.A.-F.) Department of Pathology, St John's Providence Hospital (M.K.), Detroit, Michigan Department of Pathology, Massachusetts General Hospital, Harvard University, Boston, Massachusetts (L.L., K.V.D.V., E.O.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000497DOI Listing
April 2018

Development of Peritoneal Carcinomatosis in Epithelial Ovarian Cancer: A Review.

J Histochem Cytochem 2018 02 22;66(2):67-83. Epub 2017 Nov 22.

Department of Gynecologic Oncology, Center for Gynecologic Oncology, Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1369/0022155417742897DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5794203PMC
February 2018

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer.

N Engl J Med 2018 01;378(3):230-240

From the Departments of Gynecology (W.J.D., S.N.K.), Biometrics (K.S., H.T.), Surgical Oncology (A.G.J.A.), Pathology (K.K.V.V.), and Medical Oncology (S.N.K., G.S.S.) and the Division of Psychosocial Research and Epidemiology (J.M.K., N.K.A.), the Netherlands Cancer Institute, Amsterdam, the Center for Gynecologic Oncology Amsterdam, Amsterdam (W.J.D., S.N.K., J.V.), the Dutch Gynecologic Oncology Group (W.J.D., J.H.S.L., H.W.R.S., R.H.M.H., J.V., H.J.A., L.F.A.G.M., G.S.S.), the Department of Obstetrics and Gynecology, Academic Medical Center, Amsterdam (J.V.), the Department of Obstetrics and Gynecology, Sint Antonius Hospital, Nieuwegein (J.H.S.L.), the Department of Gynecologic Oncology, UMC Utrecht Cancer Center, University Medical Center Utrecht, Utrecht (H.W.R.S.), the Departments of Gynecology and Obstetrics (R.H.M.H.) and Surgery (I.H.J.T.H.), Catharina Hospital, Eindhoven, the Dutch Peritoneal Oncology Group (I.H.J.T.H., A.G.J.A.), the Department of Gynecologic Oncology, University of Groningen, University Medical Center Groningen, Groningen (H.J.A.), and the Department of Gynecologic Oncology, Radboud University Medical Center, Nijmegen (L.F.A.G.M.) - all in the Netherlands; and the Department of Surgery, Aarhus University Hospital, Aarhus, Denmark (V.J.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1708618DOI Listing
January 2018

Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:
Shona Hendry Roberto Salgado Thomas Gevaert Prudence A Russell Tom John Bibhusal Thapa Michael Christie Koen van de Vijver M V Estrada Paula I Gonzalez-Ericsson Melinda Sanders Benjamin Solomon Cinzia Solinas Gert G G M Van den Eynden Yves Allory Matthias Preusser Johannes Hainfellner Giancarlo Pruneri Andrea Vingiani Sandra Demaria Fraser Symmans Paolo Nuciforo Laura Comerma E A Thompson Sunil Lakhani Seong-Rim Kim Stuart Schnitt Cecile Colpaert Christos Sotiriou Stefan J Scherer Michail Ignatiadis Sunil Badve Robert H Pierce Giuseppe Viale Nicolas Sirtaine Frederique Penault-Llorca Tomohagu Sugie Susan Fineberg Soonmyung Paik Ashok Srinivasan Andrea Richardson Yihong Wang Ewa Chmielik Jane Brock Douglas B Johnson Justin Balko Stephan Wienert Veerle Bossuyt Stefan Michiels Nils Ternes Nicole Burchardi Stephen J Luen Peter Savas Frederick Klauschen Peter H Watson Brad H Nelson Carmen Criscitiello Sandra O'Toole Denis Larsimont Roland de Wind Giuseppe Curigliano Fabrice André Magali Lacroix-Triki Mark van de Vijver Federico Rojo Giuseppe Floris Shahinaz Bedri Joseph Sparano David Rimm Torsten Nielsen Zuzana Kos Stephen Hewitt Baljit Singh Gelareh Farshid Sibylle Loibl Kimberly H Allison Nadine Tung Sylvia Adams Karen Willard-Gallo Hugo M Horlings Leena Gandhi Andre Moreira Fred Hirsch Maria V Dieci Maria Urbanowicz Iva Brcic Konstanty Korski Fabien Gaire Hartmut Koeppen Amy Lo Jennifer Giltnane Marlon C Rebelatto Keith E Steele Jiping Zha Kenneth Emancipator Jonathan W Juco Carsten Denkert Jorge Reis-Filho Sherene Loi Stephen B Fox

Adv Anat Pathol 2017 Nov;24(6):311-335

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000161DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5638696PMC
November 2017

Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.

Authors:
Shona Hendry Roberto Salgado Thomas Gevaert Prudence A Russell Tom John Bibhusal Thapa Michael Christie Koen van de Vijver M V Estrada Paula I Gonzalez-Ericsson Melinda Sanders Benjamin Solomon Cinzia Solinas Gert G G M Van den Eynden Yves Allory Matthias Preusser Johannes Hainfellner Giancarlo Pruneri Andrea Vingiani Sandra Demaria Fraser Symmans Paolo Nuciforo Laura Comerma E A Thompson Sunil Lakhani Seong-Rim Kim Stuart Schnitt Cecile Colpaert Christos Sotiriou Stefan J Scherer Michail Ignatiadis Sunil Badve Robert H Pierce Giuseppe Viale Nicolas Sirtaine Frederique Penault-Llorca Tomohagu Sugie Susan Fineberg Soonmyung Paik Ashok Srinivasan Andrea Richardson Yihong Wang Ewa Chmielik Jane Brock Douglas B Johnson Justin Balko Stephan Wienert Veerle Bossuyt Stefan Michiels Nils Ternes Nicole Burchardi Stephen J Luen Peter Savas Frederick Klauschen Peter H Watson Brad H Nelson Carmen Criscitiello Sandra O'Toole Denis Larsimont Roland de Wind Giuseppe Curigliano Fabrice André Magali Lacroix-Triki Mark van de Vijver Federico Rojo Giuseppe Floris Shahinaz Bedri Joseph Sparano David Rimm Torsten Nielsen Zuzana Kos Stephen Hewitt Baljit Singh Gelareh Farshid Sibylle Loibl Kimberly H Allison Nadine Tung Sylvia Adams Karen Willard-Gallo Hugo M Horlings Leena Gandhi Andre Moreira Fred Hirsch Maria V Dieci Maria Urbanowicz Iva Brcic Konstanty Korski Fabien Gaire Hartmut Koeppen Amy Lo Jennifer Giltnane Marlon C Rebelatto Keith E Steele Jiping Zha Kenneth Emancipator Jonathan W Juco Carsten Denkert Jorge Reis-Filho Sherene Loi Stephen B Fox

Adv Anat Pathol 2017 Sep;24(5):235-251

Departments of *Pathology §§§Medical Oncology, Peter MacCallum Cancer Centre, Melbourne †The Sir Peter MacCallum Department of Oncology Departments of **Pathology ∥∥Medicine, University of Melbourne ¶¶Department of Anatomical Pathology, Royal Melbourne Hospital, Parkville #Department of Anatomical Pathology, St Vincent's Hospital Melbourne, Fitzroy ††Department of Medical Oncology, Austin Health ‡‡Olivia Newton-John Cancer Research Institute, Heidelberg §§School of Cancer Medicine, La Trobe University, Bundoora §§§§§Centre for Clinical Research and School of Medicine, The University of Queensland ∥∥∥∥∥Pathology Queensland, Royal Brisbane and Women's Hospital, Brisbane §§§§§§§§§§The Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst ∥∥∥∥∥∥∥∥∥∥Australian Clinical Labs, Bella Vista ‡‡‡‡‡‡‡‡‡‡‡‡Directorate of Surgical Pathology, SA Pathology §§§§§§§§§§§§Discipline of Medicine, Adelaide University, Adelaide, Australia ***********Department of Surgical Oncology, Netherlands Cancer Institute †††††††††††††Department of Pathology ##Divisions of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, The Netherlands ###Université Paris-Est ****INSERM, UMR 955 ††††Département de pathologie, APHP, Hôpital Henri-Mondor, Créteil ∥∥∥∥∥∥∥∥∥Service de Biostatistique et d'Epidémiologie, Gustave Roussy, CESP, Inserm U1018, Université-Paris Sud, Université Paris-Saclay ¶¶¶¶¶¶¶¶¶¶INSERM Unit U981, and Department of Medical Oncology, Gustave Roussy, Villejuif ##########Faculté de Médecine, Université Paris Sud, Kremlin-Bicêtre †††††††Department of Surgical Pathology and Biopathology, Jean Perrin Comprehensive Cancer Centre ‡‡‡‡‡‡‡University of Auvergne UMR1240, Clermont-Ferrand, France ‡‡‡‡Department of Medicine, Clinical Division of Oncology §§§§Institute of Neurology, Comprehensive Cancer Centre Vienna, Medical University of Vienna, Vienna ††††††††††††††Institute of Pathology, Medical University of Graz, Austria ∥∥∥∥European Institute of Oncology ¶¶¶¶School of Medicine ######Department of Pathology, Istituto Europeo di Oncologia, University of Milan, Milan ¶¶¶¶¶¶¶¶¶¶¶¶¶Department of Surgery, Oncology and Gastroenterology, University of Padova #############Medical Oncology 2, Veneto Institute of Oncology IOV-IRCCS, Padua, Italy †††††Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barcelona †††††††††††Pathology Department, IIS-Fundacion Jimenez Diaz, UAM, Madrid, Spain §Department of Pathology and TCRU, GZA ¶¶¶Department of Pathology, GZA Ziekenhuizen, Antwerp ∥Laboratory of Experimental Urology, Department of Development and Regeneration, KU Leuven ‡‡‡‡‡‡‡‡‡‡‡Department of Pathology, University Hospital Leuven, Leuven, Belgium ¶Department of Pathology, AZ Klina, Brasschaat ††††††Department of Pathology, GZA Ziekenhuizen, Sint-Augustinus, Wilrijk ∥∥∥Molecular Immunology Unit ‡‡‡‡‡‡Department of Medical Oncology, Institut Jules Bordet, Université Libre de Bruxelles ‡Breast Cancer Translational Research Laboratory/Breast International Group, Institut Jules Bordet **************European Organisation for Research and Treatment of Cancer (EORTC) Headquarters *******Department of Pathology, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium §§§§§§§Department of Surgery, Kansai Medical School, Hirakata, Japan #######Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea ∥∥∥∥∥∥∥∥Tumor Pathology Department, Maria Sklodowska-Curie Memorial Cancer Center ¶¶¶¶¶¶¶¶Institute of Oncology, Gliwice Branch, Gliwice, Poland ‡‡‡‡‡‡‡‡‡‡‡‡‡‡Pathology and Tissue Analytics, Roche Innovation Centre Munich, Penzberg †††††††††Institute of Pathology, Charité Universitätsmedizin Berlin ‡‡‡‡‡‡‡‡‡VMscope GmbH, Berlin ¶¶¶¶¶¶¶¶¶German Breast Group GmbH, Neu-Isenburg, Germany **********Trev & Joyce Deeley Research Centre, British Columbia Cancer Agency ††††††††††Department of Biochemistry and Microbiology, University of Victoria, Victoria Departments of ‡‡‡‡‡‡‡‡‡‡Medical Genetics #########Pathology and Laboratory Medicine ¶¶¶¶¶¶¶¶¶¶¶Department of Pathology and Laboratory Medicine, Genetic Pathology Evaluation Centre, University of British Columbia, Vancouver, BC ###########Department of Pathology and Laboratory Medicine, University of Ottawa, Ottawa, Canada §§§§§§§§§§§Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, Doha, Qatar ‡‡‡‡‡‡‡‡Department of Pathology and Laboratory Medicine, Rhode Island Hospital and Lifespan Medical Center §§§§§§§§Warren Alpert Medical School of Brown University, Providence ¶¶¶¶¶National Surgical Adjuvant Breast and Bowel Project Operations Center/NRG Oncology, Pittsburgh, PA †††Breast Cancer Research Program, Vanderbilt Ingram Cancer Center, Vanderbilt University Departments of ‡‡‡Pathology, Microbiology and Immunology ########Department of Medicine, Vanderbilt University Medical Centre *********Vanderbilt Ingram Cancer Center, Nashville §§§§§§§§§Department of Pathology, Yale University School of Medicine, New Haven ∥∥∥∥∥∥∥∥∥∥∥Department of Oncology, Montefiore Medical Centre, Albert Einstein College of Medicine ∥∥∥∥∥∥∥Montefiore Medical Center ¶¶¶¶¶¶¶The Albert Einstein College of Medicine, Bronx, NY ********Department of Pathology, Brigham and Women's Hospital #####Cancer Research Institute and Department of Pathology, Beth Israel Deaconess Cancer Center ******Harvard Medical School ¶¶¶¶¶¶¶¶¶¶¶¶Division of Hematology-Oncology, Beth Israel Deaconess Medical Center ††††††††Department of Cancer Biology ‡‡‡‡‡‡‡‡‡‡‡‡‡Dana-Farber Cancer Institute, Boston, MA ∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Medicine, Division of Medical Oncology, University of Colorado Anschutz Medical Campus, Aurora, CO ‡‡‡‡‡Department of Cancer Biology, Mayo Clinic, Jacksonville, FL ∥∥∥∥∥∥Department of Pathology and Laboratory Medicine, Indiana University, Indianapolis, IN ¶¶¶¶¶¶Cancer Immunotherapy Trials Network, Central Laboratory and Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, WA ††††††††††††Department of Pathology, New York University Langone Medical Centre ############New York University Medical School *************Perlmutter Cancer Center §§§§§§§§§§§§§Pulmonary Pathology, New York University Center for Biospecimen Research and Development, New York University ***************Department of Pathology, Memorial Sloan-Kettering Cancer Center ####Departments of Radiation Oncology and Pathology, Weill Cornell Medicine, New York, NY *****Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, TX ∥∥∥∥∥∥∥∥∥∥∥∥Pathology Department, Stanford University Medical Centre, Stanford ∥∥∥∥∥∥∥∥∥∥∥∥∥∥Department of Pathology, Stanford University, Palo Alto ***Department of Pathology, School of Medicine, University of California, San Diego §§§§§§§§§§§§§§Research Pathology, Genentech Inc., South San Francisco, CA *************Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda ¶¶¶¶¶¶¶¶¶¶¶¶¶¶Translational Sciences, MedImmune, Gaithersberg, MD §§§§§§Academic Medical Innovation, Novartis Pharmaceuticals Corporation, East Hanover ##############Translational Medicine, Merck & Co. Inc., Kenilworth, NJ.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0000000000000162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564448PMC
September 2017

Changes in the Extracellular Matrix Are Associated With the Development of Serous Tubal Intraepithelial Carcinoma Into High-Grade Serous Carcinoma.

Int J Gynecol Cancer 2017 07;27(6):1072-1081

*Department of Obstetrics and Gynaecology, Radboud University Medical Center; †Department of Biochemistry, Radboud Institute for Molecular Life Sciences; ‡Department of Pathology, Radboud University Medical Center, Nijmegen; and §Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000933DOI Listing
July 2017

Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors.

Breast Cancer Res Treat 2017 Jul 1;164(1):133-138. Epub 2017 Apr 1.

Department of Medical Oncology, GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-017-4220-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487722PMC
July 2017

Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer.

Cancer Cytopathol 2017 Mar 15;125(3):197-204. Epub 2017 Feb 15.

Department of Gynecology, Center for Gynecological Oncology, Amsterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21811DOI Listing
March 2017

Using DRS during breast conserving surgery: identifying robust optical parameters and influence of inter-patient variation.

Biomed Opt Express 2016 Dec 17;7(12):5188-5200. Epub 2016 Nov 17.

Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam The Netherlands; MIRA Institute, University Twente, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1364/BOE.7.005188DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5175562PMC
December 2016

Is Urinary Lipoarabinomannan the Result of Renal Tuberculosis? Assessment of the Renal Histology in an Autopsy Cohort of Ugandan HIV-Infected Adults.

PLoS One 2015 21;10(4):e0123323. Epub 2015 Apr 21.

Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda; Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0123323PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4405591PMC
April 2016

Accuracy of Lipoarabinomannan and Xpert MTB/RIF Testing in Cerebrospinal Fluid To Diagnose Tuberculous Meningitis in an Autopsy Cohort of HIV-Infected Adults.

J Clin Microbiol 2015 Aug 10;53(8):2667-73. Epub 2015 Jun 10.

Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1128/JCM.00624-15DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508395PMC
August 2015

Diagnostic Performance of Dedicated Axillary T2- and Diffusion-weighted MR Imaging for Nodal Staging in Breast Cancer.

Radiology 2015 May 15;275(2):345-55. Epub 2014 Dec 15.

From the Department of Surgery (R.J.S., M.L.P., E.M.H., K.B.K., M.L.S.), Department of Radiology and Nuclear Medicine (R.J.S., M.L.P., R.G.H.B.T., B.B., M.B.I.L.), GROW School for Oncology and Developmental Biology (R.J.S., R.G.H.B.T., M.L.S.), Department of Epidemiology (P.J.N.), and Department of Pathology (B.d.V.), Maastricht University Medical Center, PO Box 5800, 6202 AZ Maastricht, the Netherlands; and Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands (K.K.v.d.V.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.14141167DOI Listing
May 2015

Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?

Int J Gynecol Pathol 2015 Jan;34(1):47-56

Wayne State University (I.W., Q.A., I.M., S.B., M.C., Z.A.W., B.A., R.T.M.) Henry Ford Hospital (A.R.M., M.A.E., D.S.S.) Memorial Sloan-Kettering Cancer Center (Y.H.) Cleveland Clinic (H.M.) Brigham and Women's Hospital (M.R.N.) Massachusetts General Hospital (K.K.V.d.V., E.O.) Department of Pathology (R.A.F.), Harper University Hospital, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PGP.0000000000000113DOI Listing
January 2015

Practice of percutaneous needle autopsy; a descriptive study reporting experiences from Uganda.

BMC Clin Pathol 2014 3;14(1):44. Epub 2014 Dec 3.

Department of Clinical Sciences, Institute of Tropical Medicine, Nationalestraat 155, 2000 Antwerpen, Belgium ; Faculty of Medicine, University of Antwerp, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1472-6890-14-44DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265453PMC
December 2014

Aggressive behavior and poor prognosis of endometrial stromal sarcomas with YWHAE-FAM22 rearrangement indicate the clinical importance to recognize this subset.

Int J Gynecol Cancer 2014 Nov;24(9):1616-22

*GROW School for Oncology and Developmental Biology and †Department of Obstetrics and Gynaecology, Maastricht University Medical Center, Maastricht, The Netherlands; ‡Department of Pathology, Institut Bergonie, Bordeaux, France; §Department of Pathology, Maastricht University Medical Center, Maastricht, The Netherlands; and ∥Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000278DOI Listing
November 2014

The detection of sentinel nodes in ovarian cancer: a feasibility study.

J Nucl Med 2014 Nov 20;55(11):1799-804. Epub 2014 Oct 20.

Department of Obstetrics and Gynaecology, Maastricht University Medical Centre, Maastricht, The Netherlands GROW, School for Oncology and Developmental Biology, Maastricht, The Netherlands; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2967/jnumed.114.144329DOI Listing
November 2014

Needle autopsy to establish the cause of death in HIV-infected hospitalized adults in Uganda: a comparison to complete autopsy.

J Acquir Immune Defic Syndr 2014 Oct;67(2):169-76

*Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium; †Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda; ‡Department of Pathology, College of Health Sciences, Makerere University, Kampala, Uganda; §Department of Pathology, Mulago Hospital Complex, Kampala, Uganda; ‖Department of Pathology, University Hospital Antwerp, University of Antwerp, Belgium; ¶Department of Diagnostic Oncology & Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands; #Joint Pathology Center, Silver Spring, MD; **Division of Infectious Diseases, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD; and ††Faculty of Medicine, University of Antwerp, Belgium.

View Article

Download full-text PDF

Source
https://insights.ovid.com/crossref?an=00126334-201410010-000
Publisher Site
http://dx.doi.org/10.1097/QAI.0000000000000290DOI Listing
October 2014

The majority of metachronous CIN1 and CIN3 lesions are caused by different human papillomavirus genotypes, indicating that the presence of CIN1 seems not to determine the risk for subsequent detection of CIN3.

Hum Pathol 2014 Feb 30;45(2):221-6. Epub 2013 Oct 30.

Department of Obstetrics and Gynaecology, GROW-School for Oncology and Developmental Biology Maastricht University Medical Centre, 6202AZ Maastricht, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2013.10.014DOI Listing
February 2014

Angiosarcomas of primary gynecologic origin: a clinicopathologic review and quantitative analysis of survival.

Int J Gynecol Cancer 2014 Jan;24(1):4-12

*GROW, School for Oncology and Developmental Biology, Departments of †Obstetrics and Gynecology, ‡Internal Medicine, §Epidemiology, and ∥Pathology, Maastricht University Medical Center, Maastricht; and ¶Department of Pathology, Atrium Medisch Centrum Parkstad, Heerlen, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000020DOI Listing
January 2014

Molecular biomarkers in cervical cancer diagnosis: a critical appraisal.

Expert Opin Med Diagn 2013 Jul 19;7(4):365-77. Epub 2013 Jun 19.

Maastricht University Medical Centre, GROW-School for Oncology and Developmental Biology, Department of Obstetrics and Gynaecology, PO Box 616, 6200MD Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17530059.2013.808621DOI Listing
July 2013

Oncogene alterations in endometrial carcinosarcomas.

Hum Pathol 2013 May 28;44(5):852-9. Epub 2012 Nov 28.

Department of Pathology, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Sevilla, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2012.07.027DOI Listing
May 2013

Sentinel node in ovarian cancer: study protocol for a phase 1 study.

Trials 2013 Feb 15;14:47. Epub 2013 Feb 15.

Department of Obstetrics and Gynecology, Maastricht University Medical Centre, PO Box 5800 6202 AZ, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1745-6215-14-47DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3577513PMC
February 2013

Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.

J Clin Endocrinol Metab 2012 Apr 22;97(4):E591-601. Epub 2012 Feb 22.

Department of Obstetrics and Gynaecology, Maastricht University Medical Centre, P. Debyelaan 25, 6202 AZ Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
https://academic.oup.com/jcem/article-lookup/doi/10.1210/jc.
Publisher Site
http://dx.doi.org/10.1210/jc.2011-2994DOI Listing
April 2012

Neoplastic transformation of endocervicosis into an extraovarian mucinous cystadenocarcinoma.

Hum Pathol 2011 May 15;42(5):743-8. Epub 2011 Jan 15.

GROW, School for Oncology and Developmental Biology, University of Maastricht/Maastricht University Medical Center, 6202AZ Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2010.08.017DOI Listing
May 2011

Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors.

Mod Pathol 2011 Mar 19;24(3):463-70. Epub 2010 Nov 19.

Department of Pathology, GROW, School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, The Netherlands.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/modpathol2010214
Publisher Site
http://dx.doi.org/10.1038/modpathol.2010.214DOI Listing
March 2011

Micro-RNA signature of the epithelial-mesenchymal transition in endometrial carcinosarcoma.

J Pathol 2011 Jan 29;223(1):72-80. Epub 2010 Oct 29.

Department of Pathology, Hospital Universitario Virgen del Rocío-IBIS, Instituto de Biomedicina de Sevilla, Sevilla, Spain.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/path.2802
Publisher Site
http://dx.doi.org/10.1002/path.2802DOI Listing
January 2011

Expression of aberrantly glycosylated Mucin-1 in ovarian cancer.

Histopathology 2010 Oct;57(4):597-606

Department of Internal Medicine, Division of Haematology, Maastricht University Medical Center, Maastricht, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2559.2010.03667.xDOI Listing
October 2010

Miscellaneous Pseudotumors and Mesenchymal Tumors of the Female Genital Tract.

Surg Pathol Clin 2009 Dec 29;2(4):755-83. Epub 2009 Nov 29.

Department of Pathology, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.path.2009.08.018DOI Listing
December 2009

Unsuccessful resuscitation of a preterm infant due to a pneumothorax and a masked tension pneumopericardium.

Resuscitation 2008 Aug 15;78(2):236-9. Epub 2008 May 15.

Department of Neonatal Intensive Care, University Hospital Antwerp, Wilrijkstraat 10, 2650 Edegem, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.resuscitation.2008.02.025DOI Listing
August 2008

Expression and localization of CHODLDeltaE/CHODLfDeltaE, the soluble isoform of chondrolectin.

Cell Biol Int 2007 Nov 26;31(11):1323-30. Epub 2007 May 26.

Laboratory of Molecular Biotechnology, Department of Biomedical Sciences, Faculty of Medicine, University of Antwerp, Universiteitsplein 1, B-2610 Wilrijk, and Antwerp University Hospital, Edegem, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cellbi.2007.05.014DOI Listing
November 2007

The host's genetic background determines the extent of angiogenesis induced by schistosome egg antigens.

Acta Trop 2006 Oct 27;99(2-3):243-51. Epub 2006 Sep 27.

Department of Pathology, Antwerp University, Universiteitsplein 1, B-2610 Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.actatropica.2006.08.011DOI Listing
October 2006

LacdiNAc- and LacNAc-containing glycans induce granulomas in an in vivo model for schistosome egg-induced hepatic granuloma formation.

Glycobiology 2006 Mar 10;16(3):237-43. Epub 2005 Nov 10.

Department of Pathology, Antwerp University, Universiteitsplein 1, B-2610 Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://academic.oup.com/glycob/article/16/3/237/716080/Lacdi
Publisher Site
http://dx.doi.org/10.1093/glycob/cwj058DOI Listing
March 2006

Discrimination between the anti-monomeric and the anti-multimeric Lewis X response in murine schistosomiasis.

Microbes Infect 2004 Nov;6(13):1125-32

Department of Parasitology, Leiden University Medical Center, PO Box 9600, 2300 RC Leiden, The Netherlands.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S128645790400234
Publisher Site
http://dx.doi.org/10.1016/j.micinf.2004.06.004DOI Listing
November 2004

Glycans of Schistosoma mansoni and keyhole limpet haemocyanin induce hepatic granulomas in vivo.

Int J Parasitol 2004 Jul;34(8):951-61

Department of Pathology, University of Antwerp, Universiteitsplein 1, B-2610, Antwerp, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijpara.2004.04.009DOI Listing
July 2004